1 3-D transperitoneal laparascopic radical prostatectomy in locally advanced high-risk prostate cancer: a prospective evaluation.

2 Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases

3 Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer

4 A phase III randomised clinical trial of perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB): study protocol.

5 Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.

6 Is there a different dose-effect relation between the primary tumor and involved lymph nodes in locally advanced non-small-cell lung cancer? A hypothesis-generating study.

7 Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.

8 Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer.

9 Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.

10 Positive circumferential resection margins following locally advanced colon cancer surgery: Risk factors and survival impact.

11 Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project

12 18F-fluorodeoxyglucose positron emission tomography/computed tomography features in locally advanced breast cancer and their correlation with molecular subtypes

13 Total Exenteration En Bloc with a Nephrectomy for Locally Advanced Cervical Cancer Invading a Pelvic Kidney-a Case Report and Literature Review.

14 Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck Unsuitable to Receive Cisplatin-Based Therapy.

15 Impact of Definitive Radiotherapy and Surgical Debulking on Treatment Outcome and Prognosis for Locally Advanced Masaoka-Koga stage III Thymoma.

16 A radiobiological and dosimetrical comparison between simultaneous integrated and sequential boost intensity-modulated arc treatment of locally advanced head-and-neck cancer

17 Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer: A single-arm, retrospective study of a regional cancer center of North India (Asia)

18 Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer

19 A comparative study of concomitant boost radiation versus concomitant boost with concurrent chemoradiation versus standard fractionation chemoradiation in locally advanced head-and-neck cancer

20 Metronomic palliative chemotherapy in locally advanced, recurrent and metastatic head-and-neck cancer: A single-arm, retrospective study of a regional cancer center of North India (Asia)

21 A comparative study of concomitant boost radiation versus concomitant boost with concurrent chemoradiation versus standard fractionation chemoradiation in locally advanced head-and-neck cancer

22 Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials

23 A radiobiological and dosimetrical comparison between simultaneous integrated and sequential boost intensity-modulated arc treatment of locally advanced head-and-neck cancer

24 Clinical and dosimetric impact of adaptive intensity-modulated radiotherapy in locally advanced head-and-neck cancer

25 locally advanced thyroglossal duct cyst carcinoma presenting as a neck mass

26 preoperative chemoradiotherapy in elderly patients with locally advanced rectal cancer

27 en bloc pancreaticoduodenectomy for locally advanced right colon cancers

28 efficacy of anti-her2 agents in combination with adjuvant or neoadjuvant chemotherapy for early and locally advanced her2-positive breast cancer patients: a network meta-analysis

29 long-term outcomes for surgical treatment in patients with locally advanced and disseminated gastric cancer combined with intraoperative photodynamic therapy

30 oncological safety of immediate rectus abdominis myocutaneous breast reconstruction in patients with locally advanced disease (stage iib and iii)

31 feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a phase ii trial

32 cell based autologous immune enhancement therapy (aiet) after radiotherapy in a locally advanced carcinoma of the cervix

33 cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment

34 stereotactic body radiotherapy (sbrt) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma

35 diagnosis and combined treatment of patients with locally advanced prostate cancer

36 the choice of optimal radiotherapy technique for locally advanced maxillary carcinoma using 3d treatment planning system

37 clinical efficacy of breast-conserving surgery combined with neoadjuvant chemotherapy for locally advanced breast cancer: a report of 81 cases

38 anti pd-l1 durvalumab combined with cetuximab and radiotherapy in locally advanced squamous cell carcinoma of the head and neck: a phase i/ii study (ducro)

39 efficacy of vandetanib in treating locally advanced or metastatic medullary thyroid carcinoma according to recist criteria: a systematic review and meta-analysis

40 oncological results of radical surgical treatment in patients with locally advanced prostate cancer

41 use of taxane-containing induction chemotherapy in combination with concurrent chemoradiotherapy in chinese patients with locally advanced nasopharyngeal carcinoma: a meta-analysis

42 evaluation of the efficacy and toxicity of protocol cisplatin, 5-fluorouracil, leucovorin compared to protocol fluorouracil, doxorubicin and mitomycin c in locally advanced and metastatic gastric cancer

43 effect of neoadjuvant chemotherapy on low-density lipoprotein (ldl) receptor and ldl receptor-related protein 1 (lrp-1) receptor in locally advanced breast cancer

44 locally advanced cancer of the esophagus, current treatment strategies and future directions

45 progression of intravesical condyloma acuminata to locally advanced poorly differentiated squamous cell carcinoma

46 neoadjuvant chemotherapy in locally advanced and borderline resectable nonsquamous sinonasal tumors (esthesioneuroblastoma and sinonasal tumor with neuroendocrine differentiation)

47 intensified neoadjuvant chemotherapy with nab-paclitaxel plus gemcitabine followed by folfirinox in a patient with locally advanced unresectable pancreatic cancer

48 selection criteria for the radical treatment of locally advanced rectal cancer

49 pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases

50 estrogen receptor (α and β) but not androgen receptor expression is correlated with recurrence, progression and survival in post prostatectomy t3n0m0 locally advanced prostate cancer in an urban greek population

51 Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study

52 Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

53 MDR1 and ERCC1 expression predict outcome of patients with locally advanced bladder cancer receiving adjuvant chemotheraphy

54 FACTORS AFFECTING DISEASE FREE AND OVERALL SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPHY (LABC) (THE 10-YEAR RESULTS)

55 Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer.

Keyword Connections

Journals

Research Groups

Bibliographies